drugset / Trial / NCT02020720

18F-DOPA-PET in Planning Surgery in Patients With Gliomas

NCT02020720

NaSingle-groupOpen-labelDiagnostic

Summary

This pilot clinical trial studies fluorine F 18 fluorodopa (18F-DOPA)-positron emission tomography (PET) in planning surgery in patients with gliomas. New imaging procedures, such as 18F-DOPA-PET scan, may help find gliomas and may help in planning surgery.

Timeline

Start
2014-01-22
Primary completion
2019-10-25
Completion
2024-01-10

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-DOPA Diagnostic / imaging agent